Patients with Neovascular Age-Related Macular Degeneration Requiring Intensive Intravitreal Aflibercept Treatment: An ARIES Post Hoc Analysis

被引：0

作者：

Sebastian Wolf

Frank G. Holz

Edoardo Midena

Eric H. Souied

George Lambrou

Tobias Machewitz

Helmut Allmeier

Paul Mitchell

机构：

[1] University of Bern,Reading Centre and Department for Ophthalmology, Inselspital, University Hospital

[2] University of Bonn,Department of Ophthalmology

[3] University of Padova,Department of Ophthalmology

[4] Université Paris Est Créteil,Department d’Ophtalmologie, Hôpital Intercommunal de Créteil

[5] Bayer Consumer Care,undefined

[6] AG,undefined

[7] Pharmaceuticals,undefined

[8] Bayer AG,undefined

[9] University of Sydney (Westmead Institute for Medical Research),undefined

来源：

Ophthalmology and Therapy | 2022年 / 11卷

关键词：

Injection-intensive; Intravitreal aflibercept; Neovascular age-related macular degeneration; Treat-and-extend; Treatment intervals; Treatment outcomes;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1793 / 1803

页数：10

共 20 条

[1]

Fauser S(2014)Suppression of intraocular vascular endothelial growth factor during aflibercept treatment of age-related macular degeneration Am J Ophthalmol 158 532-536

[2]

Schwabecker V(2016)Differential response to anti-VEGF regimens in age-related macular degeneration patients with early persistent retinal fluid Ophthalmology 123 1856-1864

[3]

Muether PS(2017)Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti-vascular endothelial growth factor therapy of macular diseases Graefes Arch Clin Exp Ophthalmol 255 1259-1273

[4]

Jaffe GJ(2021)Efficacy and safety of intravitreal aflibercept using a treat-and-extend regimen for neovascular age-related macular degeneration: the ARIES study Retina 41 1911-1920

[5]

Kaiser PK(2020)Recommendations by a UK expert panel on an aflibercept treat-and-extend pathway for the treatment of neovascular age-related macular degeneration Eye (Lond) 34 1825-1834

[6]

Thompson D(2014)Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies Ophthalmology 121 193-201

[7]

Lanzetta P(2020)Efficacy and safety of intravitreal aflibercept treat-and-extend regimens in exudative age-related macular degeneration: 52- and 96-week findings from ALTAIR Adv Ther 37 1173-1187

[8]

Loewenstein A(undefined)undefined undefined undefined undefined-undefined

[9]

Mitchell P(undefined)undefined undefined undefined undefined-undefined

[10]

Holz GF(undefined)undefined undefined undefined undefined-undefined

← 1 2 →